Latest filing published 28 Feb 2006 for Midatech Pharma US Inc., €825.
Insider track record
No signal scores available.
Daniel T. Roble: trading record in brief
Daniel T. Roble appears in our data through filings on Midatech Pharma US Inc. shares, published by SEC (Form 4). We count 2 filings, every one of them for a trade on 27 February 2006.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 28 February 2006, reports a share grant of €825 in Midatech Pharma US Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Daniel T. Roble
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 300 shares@ US$3.26Common StockSEC:0001181431-06-014773:0
- 2,100 shares@ US$3.42Common StockSEC:0001181431-06-014773:1
2 of 2 declarations